Neuro

Stratus To Be Preferred EEG Provider For NeuroX Online Neurology Healthcare System

NeuroX Specialty Physicians to Monitor Patients Remotely Using Stratus EEG Technology GRAND RAPIDS, Mich., Oct. 15, 2020 /PRNewswire/ — NeuroX, an online Neurology and Psychology clinic, and Stratus, the leader in home EEG testing, today announced that Stratus will partner with NeuroX to provide in-home video electroencephalogram (EEG) diagnostics to patients. NeuroX is […]

Late-breaking trial published in BMJ proves the efficacy of Coala Heart Monitor as part of cryptogenic stroke management

Non-invasive Coala Heart Monitor validated in real-world cryptogenic stroke patients as the main evaluation tool to help detect Atrial Fibrillation and prevent additional strokes. IRVINE, Calif., Oct. 14, 2020 /PRNewswire/ — Coala Life, a Swedish innovator in remote cardiac and respiratory monitoring, today announced the results of a late-breaking trial on cryptogenic stroke […]

Brain Scientific Seeks FDA Approval of Next-Gen NeuroCap™ EEG Cap Amidst New Data on Neurological Problems in COVID Patients

NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, has submitted a premarket 510(k) application to the United States Food and Drug Administration for its next generation NeuroCap™ device. NeuroCap™ is an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in […]

RapidAI Among the First Stroke Imaging Companies with Software Approved for Medicare New Technology Add-on Payment

Stroke Imaging Makes Significant Stride in Reimbursement. Helps U.S. Hospitals More Easily Adopt the Latest Advancements in Stroke Care SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the worldwide leader in advanced imaging for stroke, today announced Rapid LVO is among the first software products to qualify for the New Technology Add-on Payment (NTAP). […]

RapidAI Announces $25 Million in Series B Funding to Expand AI-Enhanced Cerebrovascular Imaging Worldwide

SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the worldwide leader in advanced imaging for stroke, today announced a $25 million Series B round of funding by Lennertz & Co. Building on years of profitability, these additional funds will accelerate the company’s strategic growth initiatives around the world. Founded in 2011, RapidAI makes the […]

Stryker’s Neuroform Atlas® Stent System granted an expanded indication, providing a new option for patients with aneurysms in the back of the brain

KALAMAZOO, Michigan, USA, Aug. 3, 2020 /PRNewswire/ — Stryker announced today that it has received U.S. Food and Drug Administration (FDA) approval for an expanded indication of its Neuroform Atlas Stent System, becoming the first and only adjunctive stent approved for use in the posterior (back of the brain) circulation.  Aneurysms in the posterior […]

Cerus Endovascular Receives CE Mark Approval for its CerusEndo MC 021 Microcatheter

Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020 FREMONT, Calif. and OXFORD, United Kingdom, July 28, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its state of the art CerusEndo MC 021 microcatheter, designed to […]

Synchron Secures Further Funding from the Australian Government to Advance Commercialization of Stentrode

Synchron’s Stentrode is a fully-implantable brain-computer interface being designed to enable people with paralysis to restore functional independence by engaging in activities of daily living SAN FRANCISCO & NEW YORK CITY & MELBOURNE, Australia–(BUSINESS WIRE)–Synchron Inc., a neurovascular bioelectronic medicine company, today announced that the Company has been awarded nearly AUD$1M […]

Balt Receives CE Mark and Performs First-in-Man for the Silk Vista Flow Diverter

MONTMORENCY, France–(BUSINESS WIRE)–Balt (www.balt-corp.com) announced today it has received CE Mark Approval for its Silk Vista flow diverting stent to treat patients with unruptured intracranial aneurysms, enabling commercialization in over 30 countries in and around the European Union. Flow diverters are intended to divert blood flow away from an aneurysm, […]